AI-Driven Remote Cardiac Rehab Market Report 2026

The artificial intelligence (AI)-driven remote cardiac rehab market size has grown exponentially in recent years. It will grow from $1.4 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 21.4%. The growth in the historic period can be attributed to expansion of cardiac rehabilitation programs, rising prevalence of cardiovascular diseases, increased adoption of telehealth services, growth of wearable cardiac devices, improved remote monitoring capabilities.

The artificial intelligence (AI)-driven remote cardiac rehab market size is expected to see exponential growth in the next few years. It will grow to $3.66 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing investments in ai-based cardiac care, rising demand for home-based rehabilitation, expansion of cloud-based cardiac analytics platforms, growing focus on preventive cardiac health, increasing integration with digital health records. Major trends in the forecast period include increasing use of AI-driven cardiac monitoring algorithms, rising adoption of wearable heart monitoring devices, growing demand for personalized rehab programs, expansion of remote patient engagement tools, enhanced focus on continuous outcome tracking.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the artificial intelligence (AI)-driven remote cardiac rehab market in the coming years. Cardiovascular diseases include disorders of the heart and blood vessels, such as heart attack, stroke, and hypertension. The rise in these diseases is largely linked to unhealthy lifestyles that contribute to obesity, high blood pressure, and elevated cholesterol, placing stress on the heart and arteries. AI-driven remote cardiac rehab supports patients by monitoring heart health, personalizing exercise and medication plans, and providing real-time feedback remotely, enhancing recovery, adherence, and reducing hospital readmissions. For example, in August 2025, the National Institutes of Health, a US government agency, projected that between 2025 and 2050, the prevalence of cardiovascular diseases would increase by 90%, mortality by 73%, and DALYs by 55%, with deaths rising from 20.5 million to 35.6 million. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the AI-driven remote cardiac rehab market.

Key companies in the AI-driven remote cardiac rehab market are focusing on developing innovative solutions, such as advanced connected health platforms, to enable continuous remote monitoring, personalized rehabilitation programs, and improved patient engagement for better cardiovascular outcomes. An advanced connected health platform is a digital system that integrates wearable devices, sensors, mobile applications, and cloud-based analytics to remotely monitor patient health, deliver personalized care, and facilitate real-time communication between patients and healthcare providers. For instance, in July 2025, OMRON Healthcare, a Japan-based healthcare company, partnered with Tricog Health Services Pvt Limited, an India-based medtech company, to launch KeeboHealth. The platform is designed to address India’s cardiac health challenges and advance OMRON’s Going for Zero vision, aimed at eliminating cardiovascular events such as heart attacks and strokes. It enables real-time monitoring using OMRON’s home ECG and blood pressure devices combined with Tricog’s AI cardiac analysis, allowing early detection of heart issues and timely medical intervention. The platform helps reduce hospitalizations, improves therapy adherence, and supports personalized heart health management.

In December 2024, Lupin Digital Health Ltd., an India-based pharmaceutical company, partnered with Medicover Hospitals to provide advanced post-operative cardiac rehabilitation. This collaboration aims to transform cardiac care in India by delivering personalized, technology-enabled at-home rehabilitation and continuous monitoring through Lupin Digital Health’s Lyfe platform, enhancing patient recovery and adherence. Medicover Hospitals is an India-based healthcare provider specializing in AI-driven remote cardiac rehabilitation.

Major companies operating in the artificial intelligence (AI)-driven remote cardiac rehab market are Medtronic PLC, Philips Healthcare, Biofourmis Inc., Neurosoft Ltd., Cadence Health Solutions, Wellframe Inc., Amwell, Datos Health Ltd., VivaLNK Inc., Carda Health Inc., Heartbeat Health Inc., Cardihab Pty Ltd., Chanl Health Inc., HealthSnap Inc., Kento Health Inc., Lyfe by Lupin Digital Health, Movn Health Inc., RecoveryPlus Health, Wellinks Inc., CardioCare Fit.

North America was the largest region in the artificial intelligence (AI)-driven remote cardiac rehab market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven remote cardiac rehab market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-driven remote cardiac rehab market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the ai-driven remote cardiac rehab market by increasing costs of imported wearable sensors, cardiac monitoring devices, mobile hardware, and cloud analytics infrastructure. Hospitals and rehabilitation centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces pricing pressure on electronics manufacturing. These tariffs are raising program implementation costs and slowing adoption in cost-sensitive settings. However, they are also encouraging domestic device production, regional software innovation, and development of scalable remote cardiac rehabilitation solutions.

The artificial intelligence (AI)-driven remote cardiac rehab market research report is one of a series of new reports that provides artificial intelligence (AI)-driven remote cardiac rehab market statistics, including artificial intelligence (AI)-driven remote cardiac rehab industry global market size, regional shares, competitors with a artificial intelligence (AI)-driven remote cardiac rehab market share, detailed artificial intelligence (AI)-driven remote cardiac rehab market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-driven remote cardiac rehab industry. This artificial intelligence (AI)-driven remote cardiac rehab market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI)-driven remote cardiac rehab is a technology-based program that uses AI to monitor and analyze a patient’s heart health and rehabilitation progress remotely. It provides personalized exercise plans, medication reminders, and real-time guidance through wearable devices and telehealth platforms.

The main components of AI-driven remote cardiac rehab include software, hardware, and services. Software consists of programs, instructions, and data that guide digital devices to perform specific tasks. These platforms are delivered via web-based, app-based, and telehealth solutions and deployed through cloud-based or on-premises models. Applications include chronic heart failure, post-myocardial infarction care, post-cardiac surgery recovery, hypertension management, and more, serving end-users such as hospitals and clinics, homecare settings, rehabilitation centers, and others.

The artificial intelligence (AI)-driven remote cardiac rehab market consists of revenues earned by entities by providing services such as remote patient monitoring, teleconsultation, personalized exercise coaching, dietary and lifestyle counseling, mental health support, medication management, and data analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-driven remote cardiac rehab market also includes sales of wearable heart rate monitors, blood pressure monitors, electrocardiogram devices, pulse oximeters, and fitness trackers. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.